NEUROTECH USA, INC.

Patent Owner

Follow Compare

Stats

Details

Technologies

Intl Class Technology # of Patents Rank
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2399
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16178
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 864
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 4152
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 496
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 389
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 374
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 386
 
 
 
C07K PEPTIDES 286
 
 
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS133

Top Patents (by citation)

Patent # Title Filing Date Issue Date Intl Class Cited #
5,871,487 Microdrive for use in stereotactic surgeryMar 10, 97Feb 16, 99[A61B]120
6,231,879 Biocompatible devices with foam scaffoldsFeb 09, 99May 15, 01[A61K]107
5,639,275 Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsulesMay 25, 95Jun 17, 97[C12N, A01N, A61K]72
5,550,050 Method for implanting encapsulated cells in a hostApr 15, 94Aug 27, 96[C12N]51
5,904,144 Method for treating ophthalmic diseasesMar 22, 96May 18, 99[A61B]50
5,834,029 Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragmentJul 20, 94Nov 10, 98[C12N, A61B, A61K]48
5,676,943 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsulesMay 25, 95Oct 14, 97[A01N, C62N]43
5,643,286 Microdrive for use in stereotactic surgeryJun 24, 94Jul 01, 97[A61B]43
6,299,895 Device and method for treating ophthalmic diseasesApr 27, 99Oct 09, 01[C12N, A61F]40
5,795,790 Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organsMay 23, 95Aug 18, 98[C12N, A61K]40

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2012/0141,573 Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Soluble Receptors and Uses ThereofNov 30, 11Jun 07, 12[C12N, A61P, A61K]
2011/0236,457 Micronized Device for the Delivery of Biologically Active Molecules and Methods of Use ThereofDec 18, 06Sep 29, 11[A61P, A61K]
2011/0111,008 Use of PEDF in an Encapsulated Cell-Based Delivery SystemOct 06, 10May 12, 11[C12N, A61F, A61K]
2010/0272,780 CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOFApr 21, 10Oct 28, 10[C12N, A61P, A61F, A61K]
2009/0269,319 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryJul 08, 09Oct 29, 09[A61P, A61K]
2009/0269,389 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryJul 07, 09Oct 29, 09[C12N, A61P]
2007/0154,524 Micronized device for the delivery of biologically active molecules and methods of use thereofDec 18, 06Jul 05, 07[A61F, A61K]
2007/0071,734 ARPE-19 as platform cell line for encapsulated cell-based deliveryOct 03, 06Mar 29, 07[A61F, A61K]
2003/0120,059 Cell surface molecule-induced macrophage activationJan 14, 03Jun 26, 03[C12N, C07H, C12P, C07K]
2003/0059,868 Retinal cell lines with extended life-span and their applicationsApr 27, 00Mar 27, 03[C12N, C07H, C12P]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7,820,195 Micronized device for the delivery of biologically active molecules and methods of use thereofDec 18, 06Oct 26, 10[A61K]
7,189,837 Cell surface molecule-induced macrophage activationJan 14, 03Mar 13, 07[C07H]
7,115,257 ARPE-19 as a platform cell line for encapsulated cell-based deliveryApr 06, 00Oct 03, 06[A61K]
6,649,184 Device and method for treating ophthalmic diseasesAug 20, 02Nov 18, 03[A61K]
6,627,422 Device containing cell-supporting yarn matrix encapsulated in a semi-permeable membraneDec 21, 00Sep 30, 03[C12N, A61F]
6,506,891 Cell surface molecule-induced macrophage activationJan 16, 01Jan 14, 03[C07H]
6,495,364 Mx-1 conditionally immortalized cellsMar 07, 01Dec 17, 02[C12N]
6,436,427 Device and method for treating ophthalmic diseasesOct 09, 01Aug 20, 02[A67F]
6,392,118 Mx-1 conditionally immortalized cellsMay 23, 95May 21, 02[C12N, A01K]
6,361,771 ARPE-19 as a platform cell line for encapsulated cell-based deliveryApr 05, 00Mar 26, 02[C12N, A61M, A61K]

View all patents..

Top Inventors for This Owner

Inventor Name Address # of Patent/Pub
Hammang Joseph P
Barrington, RI
26
Tao Weng
Lincoln, RI
16
Gentile Frank T
Warwick, RI
15
Winn Shelley R
Smithfield, RI
15
Aebischer Patrick
Lutry, CH
11
Doherty Edward J
Mansfield, MA
10
Holland Laura M
Providence, RI
9
Baetge E Edward
Barrington, RI
8
Cain Brian M
Everett, MA
8
Schinstine Malcolm
Bensalem, PA
8